Arkolith/Insider Trading/CGEM/Form 4

Ahmed Nadim

President and CEO, DirectorCullinan Therapeutics, Inc. (CGEM) · full profile →Form 4 · filed Feb 27, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$107K
Net Open-Market Flow
-$107K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 25, 2025Sell(S)13K$8.53$107K431K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-029199) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML